home.social

#fdaapproved — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #fdaapproved, aggregated by home.social.

  1. 🚀🎉 OMG, someone had the bright idea to map every single off-target effect of FDA-approved drugs! Because who doesn't want to read 6,200 words about drug side effects? 🤯 Thank you, EvE Bio, for providing a comprehensive dataset that only a data scientist could love. 💊📊
    owlposting.com/p/mapping-the-o #drugresearch #sideeffects #datascience #FDAapproved #healthdata #EvEBio #HackerNews #ngated

  2. 🚀🎉 OMG, someone had the bright idea to map every single off-target effect of FDA-approved drugs! Because who doesn't want to read 6,200 words about drug side effects? 🤯 Thank you, EvE Bio, for providing a comprehensive dataset that only a data scientist could love. 💊📊
    owlposting.com/p/mapping-the-o #drugresearch #sideeffects #datascience #FDAapproved #healthdata #EvEBio #HackerNews #ngated

  3. Neuralink Raises $650M to Advance Brain Implant Tech with Human Trials.

    Elon Musk’s Neuralink raises $650M to advance brain-computer tech.
    Now in human trials, helping paralyzed patients control devices by thought.
    Backed by FDA breakthrough status and major investors.

    #Neuralink #BrainTech #ElonMusk #Neurotechnology #BCI #ParalysisRecovery #FDAApproved #AI #TechForGood #FutureOfMedicine #BrainImplants

  4. Neuralink Raises $650M to Advance Brain Implant Tech with Human Trials.

    Elon Musk’s Neuralink raises $650M to advance brain-computer tech.
    Now in human trials, helping paralyzed patients control devices by thought.
    Backed by FDA breakthrough status and major investors.

  5. Neuralink Raises $650M to Advance Brain Implant Tech with Human Trials.

    Elon Musk’s Neuralink raises $650M to advance brain-computer tech.
    Now in human trials, helping paralyzed patients control devices by thought.
    Backed by FDA breakthrough status and major investors.

    #Neuralink #BrainTech #ElonMusk #Neurotechnology #BCI #ParalysisRecovery #FDAApproved #AI #TechForGood #FutureOfMedicine #BrainImplants

  6. Bristol Myers Squibb has scored a significant victory with the FDA's approval of Cobenfy, a groundbreaking schizophrenia treatment! 🎉 This marks the first new type of schizophrenia drug in over 30 years, offering hope to millions. With its unique mechanism, Cobenfy aims to reduce symptoms without the common side effects of older medications. 💊✨ #MentalHealth #Schizophrenia #Cobenfy #FDAApproved #PharmaInnovation

    🔗 reuters.com/business/healthcar

  7. Bristol Myers Squibb has scored a significant victory with the FDA's approval of Cobenfy, a groundbreaking schizophrenia treatment! 🎉 This marks the first new type of schizophrenia drug in over 30 years, offering hope to millions. With its unique mechanism, Cobenfy aims to reduce symptoms without the common side effects of older medications. 💊✨ #MentalHealth #Schizophrenia #Cobenfy #FDAApproved #PharmaInnovation

    🔗 reuters.com/business/healthcar

  8. Bristol Myers Squibb has scored a significant victory with the FDA's approval of Cobenfy, a groundbreaking schizophrenia treatment! 🎉 This marks the first new type of schizophrenia drug in over 30 years, offering hope to millions. With its unique mechanism, Cobenfy aims to reduce symptoms without the common side effects of older medications. 💊✨ #MentalHealth #Schizophrenia #Cobenfy #FDAApproved #PharmaInnovation

    🔗 reuters.com/business/healthcar

  9. Bristol Myers Squibb has scored a significant victory with the FDA's approval of Cobenfy, a groundbreaking schizophrenia treatment! 🎉 This marks the first new type of schizophrenia drug in over 30 years, offering hope to millions. With its unique mechanism, Cobenfy aims to reduce symptoms without the common side effects of older medications. 💊✨

    🔗 reuters.com/business/healthcar

  10. Bristol Myers Squibb has scored a significant victory with the FDA's approval of Cobenfy, a groundbreaking schizophrenia treatment! 🎉 This marks the first new type of schizophrenia drug in over 30 years, offering hope to millions. With its unique mechanism, Cobenfy aims to reduce symptoms without the common side effects of older medications. 💊✨ #MentalHealth #Schizophrenia #Cobenfy #FDAApproved #PharmaInnovation

    🔗 reuters.com/business/healthcar

  11. Why Don’t #We Have #Addiction #vaccines ?

    After three decades of #research people with addiction still have few #medication options. While there are a handful of modestly effective #fdaapproved #drugs to treat #alcohol #nicotine and #opioiduse #disorders there are none at all for #cocaine #methamphetamine and other #narcotics And the fact remains that most people with a substance use disorder will relapse …

    drugabuse.com/blog/why-dont-we